---
$id: https://graph.org.ai/products/commodity/51372022
$type: Product
source: UNSPSC
code: "51372022"
title: "Buprenorphine hydrochloride"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Buprenorphine hydrochloride

**UNSPSC Code**: 51372022
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56W8MW3EN1. European Medicines Agency schedules Buprenorphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13133MIG. Buprenorphine hydrochloride generally arises in the molecular formula C29H41NO4.CLH. The term 'buprenorphine hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule buprenorphine hydrochloride under HS 29391100 and SITC 54141. As of Q4 2014, BUPRENORPHINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Buprenorphine hydrochloride bears US NLM identifiers UMLS ID C0006404 and NCI Concept Code C47424. SMILES: C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6C5C(C(CC6)O)O4)CC7CC7)OC)(C(C)(C)C)O.CL.

